Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Real-World Cost–Effectiveness of Primary Prophylaxis with G-CSF Biosimilars in Patients at Intermediate/High Risk of Febrile Neutropenia
PaperCitations, authors & open-access status
Real-World Cost–Effectiveness of Primary Prophylaxis with G-CSF Biosimilars in Patients at Intermediate/High Risk of Febrile Neutropenia is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 6 citations, 2022 year and hybrid oa status.
6
Citations
2022
Year
hybrid
OA Status